Waldencast (WALD) Projected to Post Quarterly Earnings on Monday

Waldencast (NASDAQ:WALD) is anticipated to issue its Q2 2025 quarterly earnings data before the market opens on Monday, August 18th. Analysts expect the company to announce earnings of ($0.10) per share and revenue of $71.93 million for the quarter.

Waldencast Stock Performance

Shares of Waldencast stock opened at $1.73 on Friday. The company’s fifty day simple moving average is $2.25 and its 200-day simple moving average is $2.67. Waldencast has a 1-year low of $1.60 and a 1-year high of $4.74. The company has a current ratio of 1.35, a quick ratio of 0.66 and a debt-to-equity ratio of 0.21.

Wall Street Analyst Weigh In

A number of equities analysts recently commented on the stock. Industrial Alliance Securities set a $5.00 price target on shares of Waldencast in a research note on Tuesday, April 22nd. Canaccord Genuity Group dropped their price target on shares of Waldencast from $6.00 to $5.00 and set a “buy” rating for the company in a research note on Thursday, May 15th. Wall Street Zen cut shares of Waldencast from a “hold” rating to a “sell” rating in a research note on Thursday, May 22nd. Alliance Global Partners reissued a “buy” rating on shares of Waldencast in a research report on Thursday, May 15th. Finally, Telsey Advisory Group reissued an “outperform” rating and issued a $4.00 price objective on shares of Waldencast in a research report on Wednesday. One analyst has rated the stock with a sell rating, one has issued a hold rating and five have given a buy rating to the stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $5.11.

Institutional Trading of Waldencast

Institutional investors and hedge funds have recently bought and sold shares of the business. Jane Street Group LLC acquired a new position in shares of Waldencast during the 1st quarter worth $77,000. Rhumbline Advisers raised its holdings in Waldencast by 15.2% in the first quarter. Rhumbline Advisers now owns 61,630 shares of the company’s stock valued at $185,000 after buying an additional 8,151 shares during the period. Geode Capital Management LLC grew its position in Waldencast by 62.2% in the second quarter. Geode Capital Management LLC now owns 586,566 shares of the company’s stock valued at $1,437,000 after acquiring an additional 224,905 shares in the last quarter. Invesco Ltd. acquired a new stake in Waldencast in the second quarter valued at approximately $26,000. Finally, MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its stake in shares of Waldencast by 57.9% in the second quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 23,130 shares of the company’s stock worth $57,000 after buying an additional 8,485 shares during the last quarter. Hedge funds and other institutional investors own 41.97% of the company’s stock.

Waldencast Company Profile

Waldencast plc operates in the beauty and wellness business. The company engages in developing, acquiring, accelerating, and scaling various brands. It provides cosmetic, over-the-counter, and prescription products under the Obagi Medical, Obagi Clinical, and Obagi Professional brands; and a Skintrinsiq device for use in facial treatments that is used by physicians' offices, spas, and aestheticians.